United Therapeutics (UTHR) Tops Q2 EPS by $1.14
United Therapeutics (NASDAQ: UTHR) reported Q2 EPS of $3.63 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
